Abstract
The aim of this study was to evaluate the effect of hormone replacement therapy (HRT) on the expression of Ki-67, bcl-2 and c-erb.B2 in endometrial polyps during menopause. Sixteen patients using HRT and 24 untreated controls with endometrial polyps were enrolled in this study. Polypectomy was carried out by hysteroscopy. The presence of c-erb.B2, bcl-2 and Ki-67 expression was determined by immunohistochemistry. HRT was found to decrease Ki-67 and bcl-2 expression in endometrial polyps without affecting the c-erb.B2 staining reaction. HRT may cause endometrial polyp involution by decreasing proliferation and stimulating apoptosis.
MeSH terms
-
Administration, Cutaneous
-
Administration, Oral
-
Aged
-
Case-Control Studies
-
Endometrial Neoplasms / metabolism*
-
Estradiol / pharmacology
-
Estrogen Replacement Therapy*
-
Estrogens, Conjugated (USP) / pharmacology
-
Female
-
Humans
-
Immunohistochemistry
-
Ki-67 Antigen / metabolism
-
Medroxyprogesterone Acetate / pharmacology
-
Menopause
-
Middle Aged
-
Norethindrone / analogs & derivatives*
-
Norethindrone / pharmacology
-
Norethindrone Acetate
-
Polyps / metabolism*
-
Proto-Oncogene Proteins c-bcl-2 / metabolism
-
Receptor, ErbB-2 / metabolism
-
Retrospective Studies
Substances
-
Estrogens, Conjugated (USP)
-
Ki-67 Antigen
-
Proto-Oncogene Proteins c-bcl-2
-
Estradiol
-
Norethindrone Acetate
-
Medroxyprogesterone Acetate
-
Receptor, ErbB-2
-
Norethindrone